Potassium canrenoate (PC), a competitive aldosterone antagonist used as a d
iuretic and in the treatment of hypertension, was examined for its capacity
to produce genotoxic effects in cultured rat and human cells. At subtoxic
concentrations (10-90 mu M) PC was found to induce a dose-dependent degree
of DNA fragmentation, as detected by the Comet assay, and of DNA repair syn
thesis, as measured by quantitative autoradiography, in primary cultures of
hepatocytes from rat and human donors of both genders. In rat hepatocytes
both DNA fragmentation and DNA repair were more marked after 3 h than after
20 h exposure and in cultures from females than from males. In human hepat
ocytes from one male and two female donors, PC caused a similar effect in t
erms of DNA fragmentation, whereas DNA repair was detected in cultures from
only two of the same three donors and was less marked than in rat hepatocy
tes. A modest but statistically significant increase in micronucleated cell
s was present in primary cultures of replicating rat hepatocytes exposed to
10 or 30 mu M PC for 48 h, the response being, in this case also, more evi
dent in females than in males. In contrast, PC did not induce micronucleus
formation in human hepatocytes from two female donors. Any evidence of DNA
fragmentation and micronucleus formation was absent in cultured human lymph
ocytes, Taken as a whole these findings support the hypothesis that hepatoc
ytes activate PC to DNA-damaging reactive species. PC induced the observed
genotoxic effects at concentrations close to those produced in humans by th
e administration of therapeutic doses, but these effects were as a whole mo
re marked in rat than in human hepatocytes, Since PC shares the 17-hydroxy-
3-oxopregna-4,6-diene structure with cyproterone acetate, chlormadinone ace
tate and megestrol acetate, previously found to be genotoxic to both rat an
d human hepatocytes, the potential carcinogenic hazard of this type of ster
oids cannot be neglected.